High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

Gynecologic Oncology

Volumn 76, Issue 3, 2000, Pages 320-325

  Ryu, Hee Sug ^a   Chang, Ki Hong ^a   Yang, Hyun Won ^a   Kim, Myung Shin ^a   Kwon, Hyuck Chan ^a   Oh, Kie Suk ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Apoptosis; Cervical cancer; Cyclooxygenase (COX) 2; Tumor invasion

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKERATIN;

APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMEDIATE EARLY GENE; INFLAMMATION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

EID: 0034011262     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5690     Document Type: Article

References (24)

1. Parkin D M, Muir C S, Whelan S L, Gao Y T, Ferlay J, Powel J. Cancer Incidence in Five Continents. 1992;International Agency for Research on Cancer (IARC), Lyon
2. Korean Ministry of Health & Welfare, Korean cancer registry report (1995.1.1-12.31), 1997
3. Piver M, Chung W. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol. 46:1975;507-510
4. Boyce J, Fruchtet R G, Nicastri A D, Ambinvagar P C, Reinis M S, Nelson J H Jr. Prognostic factors in stage I carcinoma of the cervix. Gynecol Oncol. 12:1981;154-165
5. Burghardt E, Pickel H, Haas J, Lahousen M. Prognostic factors and operative treatment of stage IB to IIB cervical cancer. Am J Obstet Gynecol. 156:1987;988-996
6. Carenza L, Villani C. Parametrial involvement and therapeutic programming in stage IB cervical cancer. Baillieres Clin Obstet Gynecol. 2:1988;889-902
7. Inoue T, Okumura M. Prognostic significance of parametrial extension in patients with cervical carcinoma stage IB, IIA and IIB. Cancer. 54:1984;1714-1719
8. Inoue T. Prognostic significance of the depth of invasion to nodal metastases, parametrial extension, and cell types. Cancer. 54:1984;3035-3042
9. Inoue T, Chihara T, Morita K. The prognostic significance of the size of the largest nodes in metastatic carcinoma from the uterine cervix. Gynecol Oncol. 19:1984;187-193
10. Burghardt E, Pickel H, Haas J, Lahousen M. Objective results of the operative treatment of cervical cancer. Baillieres Clin Obstet Gynecol. 2:1988;987-995
11. Liotta L A, Steeg P S, Stetler-Stevenson W G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336
12. Crofford L J. COX-1 and COX-2 tissue expression: implication and predictions. J Rheumatol. 24:1997;15-19
13. Wetzka B, Nsing R, Charnock-Jones D S, Schfer W, Zahrandnik H P, Smith S K. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and preeclamptic pregnancies. Hum Reprod. 12:1997;2313-2320
14. Morita I, Schindleer M, Regier M K, Otto J C, Hori T, DeWitt D L. Different intracellular locations for prostaglandin endoperoxidase H synthase-1 and -2. J Biol Chem. 270:1995;10902-10908
15. Asselin B, Drolet P, Fortier M A. Cellular mechanisms involved during oxytocin-induced prostaglandin F2 production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Endocrinology. 138:1997;4798-4805
16. Dong Y L, Gangula P RR, Fang L, Yallampallin C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins. 52:1996;13-34
17. Subbaramaiah K, Zakim D, Weksler B B, Dannenberg A J. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med. 216:1997;201-210
18. Arslan A, Zingg H H. Regulation of COX-2 gene expression in rat uterus in vivo and in vitro. Prostaglandins. 52:1996;463-481
19. Liu X H, Yao S, Kirschenbaum A, Levine A C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and downregulates bcl-2 expression in LNCaP cells. Cancer Res. 10:1998;4245-4249
20. Hu Z, Wells P G. In vitro and in vivo biotransformation and covalent binding of benzo[a]pyrene in Gunn and RHA rats with genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. J Pharmacol Exp Ther. 262:1992;334-342
21. Tsujii M, DuBois R N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxidase synthase 2. Cell. 83:1995;493-501
22. Tsujii M, Kawano S, DuBois R N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 94:1997;3336-3340
23. DeWitt D, Smith W L. Yes, but do they still get headaches? Minireview. Cell. 83:1995;345-348
24. Needleman P, Isakson C I. Selective inhibition of cyclooxygenase-2. Sci Med. Jan/Feb:1998;26-35